Literature DB >> 3989377

Human apolipoprotein A-I isoprotein metabolism: proapoA-I conversion to mature apoA-I.

D Bojanovski, R E Gregg, G Ghiselli, E J Schaefer, J A Light, H B Brewer.   

Abstract

ProapoA-I (apoA-i+2 isoform) is the major apoA-I isoprotein secreted by the liver and intestine; however, it is a minor isoprotein in plasma and lymph where the major A-I apo-lipoprotein is mature apoA-I (apoA-I0, apoA-I-1, and apoA-I-2 isoforms). In the present report we provide evidence that apoA-I is rapidly and quantitatively converted to mature apoA-I, and the mature apoA-I isoforms are catabolized at equal rates. In these studies, human proapoA-I was isolated from thoracic duct chylomicrons collected during active fat absorption and mature apoA-I was isolated from plasma high density lipoproteins. The isolated lipoproteins were delipidated, fractionated by gel permeation chromatography, and the individual apoA-I isoforms were separated by preparative isoelectrofocusing. The metabolism of apoA-I isoproteins was studied in normal volunteers (N = 6) in a metabolic ward. In the first study proapoA-I and mature apoA-I (apoA-I0 isoform) were injected simultaneously into two normal subjects and the conversion of proapoA-I to mature apoA-I and the decay of radioactivity were followed in plasma and HDL over a 14-day period. ProapoA-I was rapidly and completely converted to mature apoA-I with a fractional rate of conversion of 4.0 pools/day. The average residence times of proapoA-I and mature apoA-I were 0.23 and 6.5 days, respectively. The mature apoA-I derived from proapoA-I had a residence time which was the same as the injected mature apoA-I.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3989377

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  12 in total

1.  Apolipoprotein A1 Baltimore (Arg10----Leu), a new ApoA1 variant.

Authors:  J A Ladias; P O Kwiterovich; H H Smith; S K Karathanasis; S E Antonarakis
Journal:  Hum Genet       Date:  1990-04       Impact factor: 4.132

2.  In vivo metabolism of proapolipoprotein A-I in Tangier disease.

Authors:  D Bojanovski; R E Gregg; L A Zech; M S Meng; C Bishop; R Ronan; H B Brewer
Journal:  J Clin Invest       Date:  1987-12       Impact factor: 14.808

3.  Increased proportion of proapolipoprotein A-I in HDL from patients with liver cirrhosis and hepatitis.

Authors:  T Matsuura; S Koga; H Ibayashi
Journal:  Gastroenterol Jpn       Date:  1988-08

4.  A novel truncated form of apolipoprotein A-I transported by dense LDL is increased in diabetic patients.

Authors:  Judit Cubedo; Teresa Padró; Maisa García-Arguinzonis; Gemma Vilahur; Inka Miñambres; Jose María Pou; Juan Ybarra; Lina Badimon
Journal:  J Lipid Res       Date:  2015-07-13       Impact factor: 5.922

Review 5.  Apolipoproteins in vascular biology and atherosclerotic disease.

Authors:  Anurag Mehta; Michael D Shapiro
Journal:  Nat Rev Cardiol       Date:  2021-10-08       Impact factor: 32.419

6.  Apolipoprotein A-I variants. Naturally occurring substitutions of proline residues affect plasma concentration of apolipoprotein A-I.

Authors:  A von Eckardstein; H Funke; A Henke; K Altland; A Benninghoven; G Assmann
Journal:  J Clin Invest       Date:  1989-12       Impact factor: 14.808

7.  In vivo metabolism of a mutant form of apolipoprotein A-I, apo A-IMilano, associated with familial hypoalphalipoproteinemia.

Authors:  P Roma; R E Gregg; M S Meng; R Ronan; L A Zech; G Franceschini; C R Sirtori; H B Brewer
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

8.  Deletion of the propeptide of apolipoprotein A-I impairs exit of nascent apolipoprotein A-I from the endoplasmic reticulum.

Authors:  R S McLeod; C Robbins; A Burns; Z Yao; P H Pritchard
Journal:  Biochem J       Date:  1994-09-15       Impact factor: 3.857

9.  ApoL1 levels in high density lipoprotein and cardiovascular event presentation in patients with familial hypercholesterolemia.

Authors:  Judit Cubedo; Teresa Padró; Rodrigo Alonso; Pedro Mata; Lina Badimon
Journal:  J Lipid Res       Date:  2016-04-25       Impact factor: 5.922

10.  ProApolipoprotein A1: a serum marker of brain metastases in lung cancer patients.

Authors:  Nicola Marchi; Peter Mazzone; Vincent Fazio; Tarek Mekhail; Thomas Masaryk; Damir Janigro
Journal:  Cancer       Date:  2008-03-15       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.